$HAE 4/A SEC Filings

Filed On	Filing
13 Jun 2025	Form 4/A: Basil Michelle L, EVP and General Counsel Received 6,755 shares as a grant or award · Granted 14,626 Non-qualified Stock Option (Right to Buy)
13 Jun 2025	Form 4/A: Galvin Roy, EVP, Chief Commercial Officer Received 5,689 shares as a grant or award · Granted 12,317 Non-qualified Stock Option (Right to Buy)
01 Nov 2011	Form 4/A: Gordon Mikael, President, Haemonetics Europe Received 1,956 shares as a grant or award ($19.6)
01 Nov 2011	Form 4/A: Concannon Brian, Director Received 12,226 shares as a grant or award ($122)
01 Nov 2011	Form 4/A: White Jonathan, VP Research and Development Received 1,956 shares as a grant or award ($19.6)
01 Nov 2011	Form 4/A: Jesse Sandra, VP & CLO Granted 15,370 Non-Qualified Stock Option (right to buy) ($943K)
11 Aug 2008	Form 4/A: Gelbman Ronald G, Director Received 272 shares as a grant or award ($2.72)
08 May 2007	Form 4/A: Concannon Brian, President, Patient Division Bought 550 shares ($21.2K)
14 Sep 2006	Form 4/A: Foote Susan Bartlett, Director Granted 20,000 Non-Qualified Stock Option
15 May 2006	Form 4/A: Popovsky Mark A, VP, Corporate Medical Director Granted 11,230 Non-Qualified Stock Option (right to buy) · Granted 15,000 Non-Qualified Stock Option (right to buy) · Granted 10,000 Non-Qualified Stock Option (right to buy) · 4 more
21 Jul 2005	Form 4/A: Lopez Alicia R, General Counsel & VP, Administ Sold 400 shares ($11.8K)
14 Jan 2004	Form 4/A: Williamson Donna C E, Director Exercised 6,000 Non-Qualified Stock Option (right to buy)

Comments